ATORVASTATIN CALCIUM | A216436 | BIOCON PHARMA LTD
Highest NADAC/Unit
$0.0700
per ea
Lowest NADAC/Unit
$0.0245
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 70377008011ATORVASTATIN 80 MG TABLET | $0.0700 | EA | Generic | — | 2026-06-17 |
| 70377008013ATORVASTATIN 80 MG TABLET | $0.0700 | EA | Generic | — | 2026-06-17 |
| 70377007911ATORVASTATIN 40 MG TABLET | $0.0379 | EA | Generic | — | 2026-06-17 |
| 70377007913ATORVASTATIN 40 MG TABLET | $0.0379 | EA | Generic | — | 2026-06-17 |
| 70377007811ATORVASTATIN 20 MG TABLET | $0.0285 | EA | Generic | — | 2026-06-17 |
| 70377007813ATORVASTATIN 20 MG TABLET | $0.0285 | EA | Generic | — | 2026-06-17 |
| 70377007711ATORVASTATIN 10 MG TABLET | $0.0245 | EA | Generic | — | 2026-06-17 |
| 70377007713ATORVASTATIN 10 MG TABLET | $0.0245 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.